SHR-1701

Clinical trials for SHR-1701 explained in plain language.

Never miss a new study

Get alerted when new SHR-1701 trials appear

Sign up with your email to follow new studies for SHR-1701, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New drug combo aims to control stage III lung cancer

Disease control Not yet recruiting

This study tests a new drug called SHR-1701 combined with chemotherapy and radiation for people with stage III lung cancer that cannot be removed by surgery. The goal is to see if adding this drug before or after standard treatment helps keep the cancer from growing. About 84 adu…

Matched conditions: SHR-1701

Phase: PHASE2 • Sponsor: Fudan University • Aim: Disease control

Last updated Jun 15, 2026 19:07 UTC

SHR-1701

Get alerted when new SHR-1701 trials appear

New drug combo aims to control stage III lung cancer